Clinical Trial Update: Safety and Efficacy of ALLO-316 in Subjects With Advanced or Metastatic Clear Cell Renal Cell Carcinoma [Phase 1]

View source ↗

Summary

A Phase 1 clinical trial update on ALLO-316 for advanced or metastatic clear cell renal cell carcinoma, noting safety and efficacy assessments; the study is cur…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Clear Cell Renal Cell Carcinoma

Drugs mentioned

• ALLO-316

Snippet

Sponsor: Allogene Therapeutics | Conditions: Advanced/Metastatic Clear Cell Renal Cell Carcinoma | Phase 1 | Status: ACTIVE_NOT_RECRUITING